1. Home
  2. CCS vs MPLT Comparison

CCS vs MPLT Comparison

Compare CCS & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$58.09

Market Cap

1.6B

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$8.19

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
MPLT
Founded
2000
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
CCS
MPLT
Price
$58.09
$8.19
Analyst Decision
Hold
Strong Buy
Analyst Count
2
15
Target Price
★ $78.00
$26.54
AVG Volume (30 Days)
173.0K
★ 352.7K
Earning Date
10-28-2026
12-03-2026
Dividend Yield
★ 2.36%
N/A
EPS Growth
N/A
★ 82.39
EPS
★ 2.09
N/A
Revenue
★ $4,117,816,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.43
N/A
P/E Ratio
$25.94
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$47.28
$7.46
52 Week High
$76.00
$40.43

Technical Indicators

Market Signals
Indicator
CCS
MPLT
Relative Strength Index (RSI) 49.56 32.55
Support Level $54.70 $7.46
Resistance Level $58.50 $14.22
Average True Range (ATR) 2.06 0.60
MACD 0.25 0.11
Stochastic Oscillator 65.51 30.68

Price Performance

Historical Comparison
CCS
MPLT

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: